PURPOSE: To evaluate the presence and relative concentrations of cytokines, known to be involved in the inflammatory cascade, in acute anterior cruciate ligament (ACL) injury. METHODS: We evaluated an extensive cytokine profile in synovial fluid from 12 patients with acute ACL injury undergoing arthroscopy compared with 15 control subjects using a BioPlex assay (Bio-Rad Laboratories, Hercules, CA) to measure the concentration of 17 inflammatory cytokines. RESULTS: In patients with acute ACL injury compared with asymptomatic control subjects, the following cytokines were identified at significantly increased concentrations (P < .001, Mann-Whitney U test) compared with control samples: interleukin 6 (105 ± 72 v 0 ± 0 pg/ml), interferon γ (1,544 ± 608 v 9 ± 7.5 pg/ml), macrophage inflammatory protein 1β (16 ± 3.8 v 0.3 ± 0.2 pg/ml), and monocyte chemotactic protein 1 (35 ± 13 v 0.5 ± 0.4 pg/ml). There was no case of a cytokine exhibiting increased levels in asymptomatic compared with symptomatic knee samples. CONCLUSIONS: This investigation identified 4 specific cytokines (interleukin 6, interferon γ, monocyte chemotactic protein 1, and macrophage inflammatory protein 1β) out of a panel of 17 inflammatory molecules for which the levels were consistently elevated in the context of ACL injury compared with non-painful, non-acutely injured knees in a volunteer population. LEVEL OF EVIDENCE: Level IV, prognostic case series.
PURPOSE: To evaluate the presence and relative concentrations of cytokines, known to be involved in the inflammatory cascade, in acute anterior cruciate ligament (ACL) injury. METHODS: We evaluated an extensive cytokine profile in synovial fluid from 12 patients with acute ACL injury undergoing arthroscopy compared with 15 control subjects using a BioPlex assay (Bio-Rad Laboratories, Hercules, CA) to measure the concentration of 17 inflammatory cytokines. RESULTS: In patients with acute ACL injury compared with asymptomatic control subjects, the following cytokines were identified at significantly increased concentrations (P < .001, Mann-Whitney U test) compared with control samples: interleukin 6 (105 ± 72 v 0 ± 0 pg/ml), interferon γ (1,544 ± 608 v 9 ± 7.5 pg/ml), macrophage inflammatory protein 1β (16 ± 3.8 v 0.3 ± 0.2 pg/ml), and monocyte chemotactic protein 1 (35 ± 13 v 0.5 ± 0.4 pg/ml). There was no case of a cytokine exhibiting increased levels in asymptomatic compared with symptomatic knee samples. CONCLUSIONS: This investigation identified 4 specific cytokines (interleukin 6, interferon γ, monocyte chemotactic protein 1, and macrophage inflammatory protein 1β) out of a panel of 17 inflammatory molecules for which the levels were consistently elevated in the context of ACL injury compared with non-painful, non-acutely injured knees in a volunteer population. LEVEL OF EVIDENCE: Level IV, prognostic case series.
Authors: Jakob T Sieker; Benedikt L Proffen; Kimberly A Waller; Kaitlyn E Chin; Naga Padmini Karamchedu; Matthew R Akelman; Gabriel S Perrone; Ata M Kiapour; Johannes Konrad; Braden C Fleming; Martha M Murray Journal: J Orthop Res Date: 2018-02-20 Impact factor: 3.494
Authors: Alexander Y Hui; William J McCarty; Koichi Masuda; Gary S Firestein; Robert L Sah Journal: Wiley Interdiscip Rev Syst Biol Med Date: 2011-08-08
Authors: Jakob T Sieker; Ugur M Ayturk; Benedikt L Proffen; Manuela H Weissenberger; Ata M Kiapour; Martha M Murray Journal: Arthritis Rheumatol Date: 2016-07 Impact factor: 10.995
Authors: Nicole M Cattano; Jeffrey B Driban; Mary F Barbe; Ryan T Tierney; Mamta Amin; Michael R Sitler Journal: J Athl Train Date: 2016-05-17 Impact factor: 2.860
Authors: Geoffrey D Abrams; Marc R Safran; Lauren M Shapiro; William J Maloney; Stuart B Goodman; James I Huddleston; Michael J Bellino; Gaetano J Scuderi Journal: Knee Surg Sports Traumatol Arthrosc Date: 2014-01-30 Impact factor: 4.342
Authors: Christopher L Mendias; Evan B Lynch; Max E Davis; Elizabeth R Sibilsky Enselman; Julie A Harning; Paul D Dewolf; Tarek A Makki; Asheesh Bedi Journal: Am J Sports Med Date: 2013-06-05 Impact factor: 6.202